Correlation Engine 2.0
Clear Search sequence regions


  • apoptosis (2)
  • cartilage (2)
  • chlorogenic acid (13)
  • factor (1)
  • gene (1)
  • low back pain (1)
  • mice (4)
  • NF κB (5)
  • retards (1)
  • Sizes of these terms reflect their relevance to your search.

    Intervertebral Disc Degeneration (IDD) is a key factor involved in low back pain (LBP) which affects approximately 540 million individuals worldwide. Chlorogenic Acid (CGA), a natural compound, exerts anti-inflammatory property in several diseases. Here, we aim to investigate the biological effect of CGA on IDD and explore the underlying mechanism. Lumbar spine instability (LSI) model in mice was utilized to mimic process of IDD. The effects of CGA in response to LSI were evaluated by luminescent imaging, micro-CT, histomorphology, and immunohistochemistry in vivo. Besides, the cytotoxicity of CGA on chondrocytes was detected by cell counting kit-8 (CCK-8) and the biological effects were assessed by polymerase chain reaction (PCR) in vitro. We found that CGA treatment dramatically suppressed the NF-κB activity in LSI mice. Moreover, administration of CGA mitigated cartilaginous endplate degeneration and postponed IDD development accompanying a decrease of inflammatory and catabolic mediators. Specifically, CGA ameliorated endplate degeneration might be related to its protective effects against endplate chondrocytes apoptosis and trans-differentiation. We further elucidated that CGA exerted these biological effects mainly by repressing NF-κB signaling in cartilage endplate. Our study has illustrated, for the first time, the curative effects as well as the latent mechanism of CGA in IDD and our results suggested that CGA administration might be used as an alternative therapy for IDD. Copyright © 2021. Published by Elsevier Inc.

    Citation

    Qinwen Ge, Jun Ying, Zhenyu Shi, Qiang Mao, Hongting Jin, Ping-Er Wang, Jiali Chen, Wenhua Yuan, Peijian Tong, Ju Li. Chlorogenic Acid retards cartilaginous endplate degeneration and ameliorates intervertebral disc degeneration via suppressing NF-κB signaling. Life sciences. 2021 Jun 01;274:119324

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33711382

    View Full Text